The Latest Research and Development Into the Antibody–Drug Conjugate, [Fam-] Trastuzumab Deruxtecan (DS-8201a), for HER2 Cancer Therapy

Chemical and Pharmaceutical Bulletin - Japan
doi 10.1248/cpb.c18-00744
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan


Related search